First-line treatment with vinorelbine (VNR) plus carboplatin (CBDCA) for patients with advanced non-small-cell lung cancer (NSCLC): MAP4/OP18 mRNA expression as marker predictive of response

1. Galan, A.
2. del Barco, S.
3. Mendez, M.
4. Esquerdo, G.
5. Cerezuela, P.
6. Huarriz, M.
7. Bandres, E.
8. Paules, A. B.
9. Gayo, J.
10. Garcia-Foncillas, J.